| Followers | 40 |
| Posts | 3050 |
| Boards Moderated | 0 |
| Alias Born | 01/14/2003 |
Tuesday, September 30, 2025 12:25:47 PM
Under the SEC’s Rule 10b-18 safe harbor, an issuer’s open-market repurchases on any single day are limited to no more than 25% of the stock’s Average Daily Trading Volume (ADTV). ADTV is measured over the four calendar weeks preceding the week of the buyback and uses U.S. market volume only. This is a safe harbor, not a hard cap—buying more than 25% is possible but falls outside the safe harbor and can raise manipulation risk.
Key details (volume-specific)
o Daily limit: Total “Rule 10b-18 purchases” by the issuer and any affiliated purchaser must not exceed 25% of ADTV for that day.
o Weekly block alternative: Once per week, an issuer may make one “block” purchase instead of using the 25% allowance for that day, provided no other Rule 10b-18 purchases occur that same day; that block is excluded from the ADTV numerator when you compute the four-week ADTV. (“Block” generally means ≥$200,000, or ≥5,000 shares with ≥$50,000, or ≥20 round lots totaling ≥150% of that day’s trading volume.)
o Market-wide trading suspension exception: In the trading session immediately following a market-wide halt, the volume cap is temporarily raised to 100% of ADTV (other conditions still apply).
o ADTV definition window: The SEC defines ADTV for Rule 10b-18 as the four calendar weeks preceding the week of the buyback; U.S. volume only counts.
Reminder: Rule 10b-18 is a non-exclusive safe harbor. Failure to meet it doesn’t automatically mean a violation, but you lose the safe harbor’s protection for that day. Other time, price, and manner conditions also must be satisfied to rely on the safe harbor.
SEC
Quick example
If the four-week ADTV is 2,000,000 shares, the safe-harbor daily capacity is 500,000 shares (25% × 2,000,000). In one week you could choose one day to make a qualifying block purchase instead of using that 25% on that day; that block would not be added into the four-week ADTV input going forward.
credit (or penalty) to AI
Key details (volume-specific)
o Daily limit: Total “Rule 10b-18 purchases” by the issuer and any affiliated purchaser must not exceed 25% of ADTV for that day.
o Weekly block alternative: Once per week, an issuer may make one “block” purchase instead of using the 25% allowance for that day, provided no other Rule 10b-18 purchases occur that same day; that block is excluded from the ADTV numerator when you compute the four-week ADTV. (“Block” generally means ≥$200,000, or ≥5,000 shares with ≥$50,000, or ≥20 round lots totaling ≥150% of that day’s trading volume.)
o Market-wide trading suspension exception: In the trading session immediately following a market-wide halt, the volume cap is temporarily raised to 100% of ADTV (other conditions still apply).
o ADTV definition window: The SEC defines ADTV for Rule 10b-18 as the four calendar weeks preceding the week of the buyback; U.S. volume only counts.
Reminder: Rule 10b-18 is a non-exclusive safe harbor. Failure to meet it doesn’t automatically mean a violation, but you lose the safe harbor’s protection for that day. Other time, price, and manner conditions also must be satisfied to rely on the safe harbor.
SEC
Quick example
If the four-week ADTV is 2,000,000 shares, the safe-harbor daily capacity is 500,000 shares (25% × 2,000,000). In one week you could choose one day to make a qualifying block purchase instead of using that 25% on that day; that block would not be added into the four-week ADTV input going forward.
credit (or penalty) to AI
It's the ratio, baby ... the EPA/AA ratio!
Recent AMRN News
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
